From Medscape Diabetes & Endocrinology

Coverage from the

European Association for the Study of Diabetes (EASD) 2019 Annual Meeting

September 16 - 20, 2019; Barcelona, Spain

September 16 - 20, 2019 Barcelona, Spain

EASD 2019 PRIORITY: Urine Test Spots Future Kidney Disease in Diabetes Proteomic test identified patients with diabetes at high risk of kidney disease before they had detectable microalbuminuria. However, spironolactone did not mitigate the risk.
Medscape Medical News, October 3, 2019
EASD 2019 Insulin Degludec Fails to Best Glargine in CONCLUDE Study Overall hypoglycemic episodes didn't differ in a head-to-head trial of the two second-generation basal insulin analogs, but both nocturnal and severe episodes were reduced with degludec.
Medscape Medical News, September 26, 2019
EASD 2019 Bariatric Surgery in Obese Type 1 Diabetes Has Pros, Cons Large registry study in Sweden sheds light on risks and benefits of bariatric surgery in patients with type 1 diabetes, stresses it's important to evaluate potential candidates on a case-by-case basis.
Medscape Medical News, September 25, 2019

Meeting Highlights At A Glance

Top News From EASD 2019: Slideshow Support for early combination therapy in newly diagnosed type 2 diabetes and "stunning" benefits with dapagliflozin in heart failure featured prominently this year.

Conference News

EASD 2019 Diabetes App Wild West: EASD/ADA Group Hopes to Spur Change
Medscape Medical News, October 10, 2019
EASD 2019 DKA at Diagnosis of Type 1 Diabetes Surges in US Kids
Medscape Medical News, October 9, 2019
EASD 2019 Reducing Obese Moms' Sitting Time Lowers Fat Mass in Newborns
Medscape Medical News, October 4, 2019
EASD 2019 PRIORITY: Urine Test Spots Future Kidney Disease in Diabetes
Medscape Medical News, October 3, 2019
EASD 2019 A1c Swings Tied to More Diabetes Complications Long Term
Medscape Medical News, October 2, 2019
EASD 2019 Dulaglutide Reduces Binge Eating in Pilot Study in Diabetes
Medscape Medical News, October 1, 2019
EASD 2019 Insulin Degludec Fails to Best Glargine in CONCLUDE Study
Medscape Medical News, September 26, 2019
EASD 2019 Bariatric Surgery in Obese Type 1 Diabetes Has Pros, Cons
Medscape Medical News, September 25, 2019
EASD 2019 'A Bad Result': A1c Targets Missed in Most With Type 1 Diabetes
Medscape Medical News, September 25, 2019
EASD 2019 IVF Associated With Higher Risk of Gestational Diabetes
Medscape Medical News, September 24, 2019
EASD 2019 SUSTAIN-8: Semaglutide vs Canagliflozin After Metformin in T2D
Medscape Medical News, September 23, 2019
Alert EASD 2019 FDA OKs 'Game-Changer' Oral GLP-1 Agonist for Type 2 Diabetes
FDA Approvals, September 20, 2019

EASD 2019 CAROLINA Published: Reaffirms Sulfonylurea Cardiovascular Safety
Medscape Medical News, September 20, 2019
EASD 2019 Cleaners and Factory Workers Have High Rates of Type 2 Diabetes
Medscape Medical News, September 19, 2019
EASD 2019 DAPA-HF Published: 'Stunning Consistent Benefit With Dapagliflozin'
Medscape Medical News, September 19, 2019
EASD 2019 Novel Agent Imeglimin Improves Glucose Control in Type 2 Diabetes
Medscape Medical News, September 19, 2019
EASD 2019 Incidence of Type 2 Diabetes Up in Younger People and Risks Greater
Medscape News UK, September 19, 2019
EASD 2019 Blood Lipid Changes at Age 8 in Kids Genetically Prone to Diabetes
Medscape Medical News, September 18, 2019
EASD 2019 CGM, Not Insulin Pump, 'Is What Makes Difference' in Type 1 Diabetes
Medscape Medical News, September 18, 2019
EASD 2019 VERIFY: Metformin + DPP-4 Inhibitor as Dual Therapy for Diabetes?
Medscape Medical News, September 18, 2019
EASD 2019 A New Drug for HF? DEFINE-HF Bolsters Dapagliflozin Cardio Cred
Medscape Medical News, September 17, 2019
EASD 2019 Vegan Diet Alters Microbiome and Insulin Sensitivity, Drops Weight
Medscape Medical News, September 17, 2019
EASD 2019 Obesity Poses Much Bigger Risk for Diabetes Than Bad Genes
Medscape Medical News, September 17, 2019
EASD 2019 What's Cooking in Diabetes? All Revealed at EASD in Barcelona
Medscape Medical News, September 9, 2019

Medscape Diabetes© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Choosing Type 2 Diabetes Guidelines: 'Shop' Carefully
Aus Alzaid, MD
Has Sitting Gotten a Bum Rap?
Aus Alzaid, MD
Teens With Obesity 'Deserve' to Be Offered Bariatric Surgery
Louise A. Baur, BSc (Med), PhD
Yes, Use Apps for Diabetes, but With Care
Anne L. Peters, MD
Recreational Marijuana in Diabetes: Not All Fun and Games
Harpreet S. Bajaj, MD, MPH
Spotlight on SGLT Inhibitors for Type 1 Diabetes: EASD 2019
Thomas Danne, MD
Using Newer Diabetes Agents: Assess the Most Pressing Need
Anne L. Peters, MD
Oral Semaglutide the 'Most Efficacious' Oral Diabetes Drug
Martin Haluzik, MD, PhD, DSc
Top Trials, Governance, and Guidelines: EASD President Prof David Matthews
Prof David Matthews
Hypoglycaemia Take Homes from EASD
Prof Simon Heller
The Big Cost to the NHS of Unmanaged Diabetes
Dr Adrian Heald
Why Diabetes Management May Need to Change for South Asians
Moneeza Siddiqui, PhD

Popular News from EASD 2018

Personalize Diabetes Therapy, New EASD-ADA Guidelines Stress Newly published document recommends treatment based on individual patient characteristics and preferences.
Medscape Medical News, Oct 08, 2018
When Does Type 2 Diabetes Start? Changes Evident 20 Years Before New evidence regarding the trajectory of prediabetes shows that metabolic abnormalities can start up to 20 years before diagnosis of type 2 diabetes, so tackle risk factors 'the sooner, the better.
Medscape Medical News, Oct 10, 2018
Insulin at Risk From Variable Temperatures of Home Refrigerators Insulin stored in a domestic refrigerator fell out of recommended temperature range (2° - 8° C) more than 11% of the time, and even dipped below zero. Carried insulin experienced much less variation (0.54%).
Medscape Medical News, Oct 04, 2018
HARMONY: Albiglutide Cuts CV Events but Not Deaths in Diabetes The GLP-1 agonist albiglutide reduces major CV events by 20% in type 2 diabetes patients with cardiovascular disease; GSK has ceased marketing the drug but say they will seek a new home for it.
Medscape Medical News, Oct 03, 2019